Syrma SGS Technology Limited

rs,

ai - 400 051. Symbol: SYRMA Department of Corporate Service BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code: 543573 Subject: Intimation under Regulation 30 of SEB

rs 1.27

er IT Railways Figures that matter ( As on 31st March 2026 ) Financial Highlights: 350+ Customers 1.27 Mn sq. ft. Manufacturing area 4 R&D facilities (Gurgaon, Pune, Chennai, Germany) 10,000+ Workfor

₹48,569

uring area 4 R&D facilities (Gurgaon, Pune, Chennai, Germany) 10,000+ Workforce, 195+ in R&D 4 ₹48,569 Mn FY26 Revenue, up 27% YoY PC* ₹5,823 Mn FY26 EBITDA up 56% YoY 17 Operational Facilities 35

27%

(Gurgaon, Pune, Chennai, Germany) 10,000+ Workforce, 195+ in R&D 4 ₹48,569 Mn FY26 Revenue, up 27% YoY PC* ₹5,823 Mn FY26 EBITDA up 56% YoY 17 Operational Facilities 35+ Export Countries Our

₹5,823

, Chennai, Germany) 10,000+ Workforce, 195+ in R&D 4 ₹48,569 Mn FY26 Revenue, up 27% YoY PC* ₹5,823 Mn FY26 EBITDA up 56% YoY 17 Operational Facilities 35+ Export Countries Our Journey: From IPO

56%

0+ Workforce, 195+ in R&D 4 ₹48,569 Mn FY26 Revenue, up 27% YoY PC* ₹5,823 Mn FY26 EBITDA up 56% YoY 17 Operational Facilities 35+ Export Countries Our Journey: From IPO To Strategic Scale O

60%

Johari acquisition → Dedicated MedTech facility, Pune (actively scaled) 2025 Elcome acquisition → 60% stake; Maritime & Defence electronics STRATEGIC JVs 2025 2025 PCB JV (Shinhyup, Korea) → Naidu

5%

y safety & reliability; enables global rail electronics supply EcoVadis Gold ESG compliance- top 5% of 130,000+ companies globally; commercial prerequisite for European OEM contracts FDA Register

54%

ets. 7 Our Business Verticals Consumer Automotive and Electric Mobility (5 Year Revenue CAGR – 54%) Industrials (5 Year Revenue CAGR – 29%) Consumer (5 Year Revenue CAGR – 48%) Healthcare & Med

29%

Automotive and Electric Mobility (5 Year Revenue CAGR – 54%) Industrials (5 Year Revenue CAGR – 29%) Consumer (5 Year Revenue CAGR – 48%) Healthcare & Medical Devices (5 Year Revenue CAGR – 26%)

48%

ear Revenue CAGR – 54%) Industrials (5 Year Revenue CAGR – 29%) Consumer (5 Year Revenue CAGR – 48%) Healthcare & Medical Devices (5 Year Revenue CAGR – 26%) 24% 30% Industries Catered (Revenue

26%

– 29%) Consumer (5 Year Revenue CAGR – 48%) Healthcare & Medical Devices (5 Year Revenue CAGR – 26%) 24% 30% Industries Catered (Revenue mix FY26) 9% 29% In d u s t r i a l s 8% Railways and

“Manufacturing area 4 R&D facilities (Gurgaon, Pune, Chennai, Germany) 10,000+ Workforce, 195+ in R&D 4 ₹48,569 Mn FY26 Revenue, up 27% YoY PC* ₹5,823 Mn FY26 EBITDA up 56% YoY 17 Operational Facilities 35+ Export Countries Our Journey: From IPO To Strategic Scale ORGANIC EXPANSION 2022 2023 2024 2024–25 Added a unit in Chennai Added units in Bawal and Manesar Pune Campus facility (~1.2 Mn.”

“mobile phones) 14,527 2,577 FY21 FY26 Healthcare & Medtech Personal Healthcare Devices Power Supplies for Medical Devices High Precision Dispensers Digital X-ray, Smart Canes Muscle Toning, Diagnostics and therapeutic devices Industry Position Esteemed Clients Performance ₹ Million • • • Global MedTech market at ~$810 Bn (2025), targeting ~$1 Trillion by 2030*.”

“We now have a foot in the door in defence applications, and we intend to increase the bouquet of offerings significantly." — J.S.”

“ECMS incentives (~50% total phased Capex reimbursed), combined with strategic location (Chennai port 108 km, Tirupati airport 50 km), make the project economics strong Phase 1: ~1.2 Mn sq.”

“26 Financial Performance for the year ended Mar’26 FINANCIAL SUMMARY – FY26 Profitability expansion continues: PBT +88% YoY and PAT +87% YoY with significant margin improvement.”

“for Goodwill)* OCF/EBITDA NWC Days FY25 8.6% 9.7% 6.2% 4.8% 0.8 0.3 12.4% 16.0% 54.5% 69 FY26 11.3% 12.0% 9.2% 7.1% NM 0.1 16.9% 20.1% 53.2% 63 * ROCE = Annualized EBIT /Average Net Capital Employed based on the Capital employed as on 31st Mar’ 26 & 31st Mar’ 25 (adjusted for goodwill).”

“for Goodwill)* NWC Days Q4 FY25 Q3 FY26 Q4 FY26 12.4% 13.7% 9.9% 7.5% 0.8 0.3 12.4% 16.0% 69 12.6% 13.3% 10.9% 8.7% NM 0.2 14.5% 17.6% 73 11.9% 12.6% 10.2% 8.1% NM 0.1 16.9% 20.1% 63 * ROCE = Annualized EBIT /Average Net Capital Employed based on the Capital employed as on 31st Mar’ 26 & 31st Mar’ 25 (adjusted for goodwill) 41”

Industries Catered

1

Financial Highlights

1

Expanded Stuttgart Facility

1

Investors Contact

1

Industries Catered

End-to-end capabilities one stop solution Sample batch Post sale lifecycle support Prototyping Industrial Automotive & EV Healthcare / MedTech Consumer IT Railways Figures that matter ( As on 31st March 2026 )

Financial Highlights

350+ Customers 1.27 Mn sq. ft. Manufacturing area 4 R&D facilities (Gurgaon, Pune, Chennai, Germany) 10,000+ Workforce, 195+ in R&D 4 ₹48,569 Mn FY26 Revenue, up 27% YoY PC* ₹5,823 Mn FY26 EBITDA up 56% YoY 17 Operational Facilities 35+ Export Countries Our Journey: From IPO To Strategic Scale ORGANIC EXPANSION 2022 2023 2024 2024–25 Added a unit in Chennai Added units in Bawal and Manesar Pune Campus facility (~1.2 Mn. sq. ft. potential)

Expanded Stuttgart Facility

From Design to Prototyping LISTING STRATEGIC ACQUISITIONS IPO (Aug 2022) - listed on NSE/BSE Pan-India manufacturing – 12 Mfg Facilities and 3 R&D SGS Tekniks merger → unified platform 2021 2023 Expansion into RFID Segment via Perfect ID Acquisition Johari acquisition → Dedicated MedTech facility, Pune (actively scaled) 2025 Elcome acquisition → 60% stake; Maritime & Defence electronics STRATEGIC JVs 2025 2025 PCB JV (Shinhyup, Korea) → Naidupeta, AP. Elemaster JV (Italy) → High-reliability for Rail & Industrial OEMs 5 Our Presence Gurugram (Manufacturing & Design Centre) Jodhpur Bawal Pune (Ranjangaon) ((Manufacturing & Design Centre) Bengaluru 6 Texas, USA (Business office) Baddi 17 Operational Manufacturing Facilities 1,267K sq. ft. Commissioned Manufacturing Plant area Manesar 4 Global R&D Centers Naidupeta, Andhra Pradesh (Upcoming PCB plant) Stuttgart, Germany (Design Centre) 195+ employees In Engineering, Design & Development Chennai (Manufacturing & Design Centre) Key Export Ma

Investors Contact

Nikhil Gupta, CFA Head – Investor Relations +91 11 4700 2122 investor.relations@syrmasgs.com www.syrmasgs.com/investor-relations/ 42 Thank you